Validating survivin as a cancer therapeutic target

DC Altieri - Nature Reviews Cancer, 2003 - nature.com
Acquisition of the ability to evade cellular suicide, or apoptosis, is one of the master switches
that contributes to cellular transformation and, ultimately, to invasive cancer. Much has been …

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

AC Mita, MM Mita, ST Nawrocki, FJ Giles - Clinical cancer research, 2008 - AACR
Survivin, a member of the family of inhibitor of apoptosis proteins, functions as a key
regulator of mitosis and programmed cell death. Initially, survivin was described as an …

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial

J Fares, AU Ahmed, IV Ulasov, AM Sonabend… - The Lancet …, 2021 - thelancet.com
Background Malignant glioma is the most common and lethal primary brain tumour, with
dismal survival rates and no effective treatment. We examined the safety and activity of NSC …

Phase IIa study of SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma

MS Ahluwalia, DA Reardon, AP Abad… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Despite intensive treatment with surgery, radiation therapy, temozolomide (TMZ)
chemotherapy, and tumor-treating fields, mortality of newly diagnosed glioblastoma (nGBM) …

Survivin, versatile modulation of cell division and apoptosis in cancer

DC Altieri - Oncogene, 2003 - nature.com
Survivin is a member of the inhibitor of apoptosis (IAP) gene family that has attracted
attention from several viewpoints of basic and translational research. Its cell cycle-regulated …

Personalized immunotherapy against several neuronal and brain tumors

S Kuttruff-coqui, T Weinschenk, J Fritsche… - US Patent …, 2021 - Google Patents
2014-11-12 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …

Survivin, a cancer target with an emerging role in normal adult tissues

S Fukuda, LM Pelus - Molecular cancer therapeutics, 2006 - AACR
Survivin, an inhibitor of apoptosis protein, is highly expressed in most cancers and
associated with chemotherapy resistance, increased tumor recurrence, and shorter patient …

Immunotherapy advances for glioblastoma

DA Reardon, G Freeman, C Wu, EA Chiocca… - Neuro …, 2014 - academic.oup.com
Survival for patients with glioblastoma, the most common high-grade primary CNS tumor,
remains poor despite multiple therapeutic interventions including intensifying cytotoxic …

Survivin: a promising tumor biomarker

MJ Duffy, N O'Donovan, DJ Brennan, WM Gallagher… - Cancer letters, 2007 - Elsevier
Survivin is a 16.5 kDa protein overexpressed in almost all malignancies but rarely detected
in normal differentiated adult tissues. Functionally, survivin has been shown to inhibit …

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

ZG Lu, J Shen, J Yang, JW Wang, RC Zhao… - … and Targeted Therapy, 2023 - nature.com
Nucleic acid drugs have the advantages of rich target selection, simple in design, good and
enduring effect. They have been demonstrated to have irreplaceable superiority in brain …